Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome

Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Otto, Matthias, Krebs, Jörg, Welker, Peter, Holm, René, Thiel, Manfred, Gattinoni, Luciano, Quintel, Michael, Tsagogiorgas, Charalambos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004724/
https://www.ncbi.nlm.nih.gov/pubmed/33806903
http://dx.doi.org/10.3390/pharmaceutics13030431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004724/
https://www.ncbi.nlm.nih.gov/pubmed/33806903
http://dx.doi.org/10.3390/pharmaceutics13030431

Ejemplares similares